rs150316320: Rare Genetic Variation in Longevity Research
rs150316320 is a low-frequency single nucleotide polymorphism that has garnered attention in genomic analyses of exceptional human longevity. Found at a minor allele frequency of under 1% in global reference databases like gnomAD, it has been evaluated in centenarian cohorts examining metabolic pathways and extracellular matrix remodeling. While cataloged among candidate loci in aging biology, evidence linking it definitively to individual lifespan remains moderate and requires broader replication.
What each genotype means
Typical baseline longevity profile
You carry two copies of the standard C reference allele at this locus. Research on human healthspan and extreme longevity cohorts indicates that this baseline genotype does not confer the altered extracellular matrix remodeling observed with the rare allele. Your trajectory for longevity and age-related health outcomes reflects standard population background risk factors.
Found in over 99% of individuals across nearly all global ancestral populations.
Longevity-associated variant carrier
You carry one copy of the rare T variant allele associated in research cohorts with healthy aging and modified extracellular matrix maintenance. Published longevity studies identify this low-frequency allele enriched among centenarian and long-lived cohorts, although its overall contribution is modest and interacts with broader lifestyle and genetic factors. Because evidence is based on specialized study populations, its personal predictive impact carries some uncertainty.
Carried by fewer than 1% to 2% of individuals globally, with minor allele frequencies typically below 0.01 in gnomAD.
Rare longevity homozygous profile
You have inherited two copies of the rare T variant allele linked to altered extracellular matrix remodeling in longevity genetics research. Due to the extremely low frequency of this allele in reference populations, direct clinical and epidemiological data for homozygotes remain very limited. Findings indicate potential metabolic and structural remodeling mechanisms, but precise physiological effects require further study.
Extremely rare across all documented populations, occurring in far fewer than 1 in 10,000 individuals.
Genomic Location and Variant Classification
The single nucleotide variant rs150316320 represents a single base change mapped within the human genome and cataloged in public repositories such as NCBI dbSNP and the Genome Aggregation Database (gnomAD). In genomic surveys of extreme longevity, researchers sequence individuals who have lived past 100 years to identify both common and rare genetic variations that might confer resilience against age-related degeneration. While common variants explain only a modest fraction of human lifespan heritability, low-frequency variations like rs150316320 are often screened to evaluate whether specific non-synonymous or regulatory changes modify cellular maintenance pathways. Reference datasets document rs150316320 as a low-frequency variant, appearing in fewer than one in one hundred alleles across broadly sampled populations.
Biological Pathways and Longevity Research
Exceptional longevity is a polygenic and multifactorial trait governed by complex genetic networks alongside lifestyle and environmental factors. Whole-genome and whole-exome association studies of centenarians have repeatedly highlighted molecular pathways related to insulin/IGF-1 signaling, metabolic regulation, cellular senescence, and extracellular matrix remodeling. Variants identified in centenarian and supercentenarian cohorts, including rs150316320, are often cross-referenced using functional prediction tools like SIFT to assess their potential molecular consequences. Preliminary studies suggest that certain rare alleles observed in long-lived cohorts may influence tissue elasticity and metabolic flexibility, although specific biochemical mechanisms downstream of rs150316320 continue to be investigated.
Strength of Scientific Evidence and Uncertainty
The evidence currently associating rs150316320 with human longevity is categorized as moderate. Unlike well-replicated loci such as APOE or FOXO3, low-frequency variants pose unique statistical challenges in genetic epidemiology. Because rare variants appear in relatively few individuals, statistical association tests—such as burden testing or kernel association tests—require very large sample sizes to achieve genome-wide significance without false positives. Cohort effects, differing ancestral backgrounds, and survivor bias can also influence findings in extreme aging studies. Consequently, scientists consider rs150316320 a compelling candidate variant within ongoing aging research rather than a definitively proven determinant of individual lifespan.
What Readers Should Keep in Mind
Discovering an association between a genetic variant like rs150316320 and longevity provides valuable biological insights, but it cannot be used to predict an individual's personal lifespan. Having or lacking a specific allele does not guarantee a longer life or predispose an individual to premature aging. Polygenic architecture dictates that thousands of variants, each with minute effect sizes, interact with lifestyle factors such as cardiovascular health, physical exercise, balanced nutrition, and social connections. Furthermore, genetic testing results for longevity variants should never be interpreted as clinical diagnoses or medical instructions, and any health-related questions should always be addressed with a qualified medical provider.
How common is this variant?
According to the Genome Aggregation Database (gnomAD), the alternative allele for rs150316320 is rare globally, displaying a minor allele frequency (MAF) well below 0.01 (1%) across diverse ancestral groups.
Frequently asked questions
Does having the rs150316320 variant mean I will live to 100?
No. Human lifespan is influenced by a combination of hundreds to thousands of genetic factors along with diet, lifestyle, access to healthcare, and environmental exposures. No single genetic variant can guarantee extreme longevity or predict how long you will live.
How common is the rs150316320 variant in the general population?
rs150316320 is considered a low-frequency variant with a minor allele frequency of less than 1% in large population databases like gnomAD. Most individuals carry two copies of the common reference allele.
What biological pathways are connected to rs150316320?
Research into centenarian genomes often focuses on variants that map to metabolic homeostasis, extracellular matrix remodeling, and cellular stress responses. However, laboratory validation of the precise functional effect of rs150316320 is still ongoing.
Can I use commercial DNA testing to check for this variant?
While whole-genome or exome sequencing can detect rs150316320, standard consumer genotyping arrays often do not capture low-frequency variants reliably. Even if detected, scientific consensus classifies it as an exploratory research finding rather than a clinical health marker.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs150316320?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
While previously linked to longevity, this variant is more prominently associated with neurodevelopmental and behavioral phenotypes, including autism spectrum disorder, through its role in polysialylation.
A genetic variant associated with the expression of the cathepsin B gene in blood, linked to extreme longevity phenotypes.
The G-allele of this variant has been associated with a positive impact on healthy lifespan in human cohorts.
A non-coding variant in the CDKN2B-AS1 locus associated with human longevity and survival beyond 90 years of age.
Variant in the APOE/APOC1 gene cluster linked to APOE isoform expression and studied for its role in neurocognitive healthspan and longevity.
Downstream variant in the APOE region associated with lipid metabolism profiles and healthspan indicators.